Literature DB >> 10884902

Drawing together: evaluation of a therapy programme for severe aphasia.

C Sacchett1, S Byng, J Marshall, C Pound.   

Abstract

This paper reports a therapy study that aims to promote communicative drawing in a group of seven people with severe and long-standing aphasia. Therapy was conducted on individual and group bases over 12 weeks and entailed a range of techniques which are described in some detail. Treatment was evaluated using a novel generative drawing assessment in which subjects were required to draw absent items in response to photographic and conversational cues. Pre- and post-therapy assessments of untreated skills, such as comprehension, naming and gesture, were also conducted. The results indicated that, as a group, the subjects' drawing improved. Unchanged performance on the other assessments indicated that the gains were specific to the content of therapy and could not be attributed to spontaneous recovery. Pre- and post-therapy interviews with carers (i.e. relatives and close friends of the individuals) suggested that the effects of therapy were also being felt in the home. These results have important implications for therapy with people with severe aphasia.

Entities:  

Mesh:

Year:  1999        PMID: 10884902     DOI: 10.1080/136828299247414

Source DB:  PubMed          Journal:  Int J Lang Commun Disord        ISSN: 1368-2822            Impact factor:   3.020


  3 in total

1.  Comparison of the neural basis for imagined writing and drawing.

Authors:  Greg S Harrington; Dana Farias; Christine H Davis; Michael H Buonocore
Journal:  Hum Brain Mapp       Date:  2007-05       Impact factor: 5.038

2.  Ambient experience in restitutive treatment of aphasia.

Authors:  Jill S McClung; Leslie J Gonzalez Rothi; Stephen E Nadeau
Journal:  Front Hum Neurosci       Date:  2010-11-02       Impact factor: 3.169

Review 3.  The role of the speech language pathologist in acute stroke.

Authors:  Cindy Dilworth
Journal:  Ann Indian Acad Neurol       Date:  2008-01       Impact factor: 1.714

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.